|
|
市场分析报告
|
Global Market Report of Tipelukast (CAS 125961-82-2) December 2024
Tipelucast (CAS 125961-82-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
CAS 125961-82-2 Tipelukast Chemical Report & Database ... listed. The substance covered (Tipelukast) are classified by the ... & Database definitions: Name: Tipelukast: Tipelukast; 4-[6-Acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl) ... Chemical or Reaction Intermediate The Tipelukast Report & Database gives Market ...
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2022 ... and tolerability profile to date. Tipelukast: MediciNova MN-001 (tipelukast) is a novel, orally bioavailable small ... Nitric oxide inhalation - INOpulse MN-001 (tipelukast) VAY736 ENV-101 PLN-74809 ...
Lipoxygenase Inhibitors - Pipeline Insight, 2022 ... -alcoholic steatohepatitis, Type 2 diabetes mellitus. Tipelukast: MediciNova Tipelukast is being developed by MediciNova and ... Qurient Therapeutics Key Products Epeleuton Tipelukast TA 270 MW 001 PTC 857 Baicalein ...
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver ...
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2028 This report can be delivered to the clients within 7-10 Business Days DelveInsight’s ‘Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding of the disease, historical & ...
Idiopathic Pulmonary Fibrosis (IPF) Market Insights, Epidemiology and Market Forecast This report can be delivered to the clients within 24 Hous DelveInsight’s ‘Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding of the disease, historical & forecasted ...
Type 4 cyclic nucleotide phosphodiesterase inhibitors - Pipeline Insight, 2022 ... Research programme: phosphodiesterase type 4 inhibitors Tipelukast Apremilast Roflumilast topical
|
|
|
|